Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/34762 |
Resumo: | 2020-08-13 |
id |
CRUZ_b0356a08baafb681a81a62ebb34bb8ae |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/34762 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Palma, Mariana L.Zamith-Miranda, DanielMartins, Flaviano S.Bozza, Fernando A.Nimrichter, LeonardoMontero-Lomeli, MônicaMarques, Ernesto T. A.Douradinha, Bruno2019-08-13T12:52:08Z2019-08-13T12:52:08Z2015PALMA, Mariana L. et al. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? Applied Microbiology and Biotechnology, v. 99, p. 6563-6570, 2015.0175-7598https://www.arca.fiocruz.br/handle/icict/3476210.1007/s00253-015-6776-x1432-0614engSpringerProbiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article2020-08-13Universidade de São Paulo. Faculdade de Medicina. Faculdade de Medicina. São Paulo, SP, Brasil / University of Pittsburgh. Center for Vaccine Research. Pittsburgh, PA, USA.Universidade Federal do Rio de Janeiro. Instituto de Microbiologia Paulo Goés. Rio de Janeiro, RJ, Brasil.Universidade Federal de Minas Gerais. Instituto de Ciências Biológicas. Departamento de Microbiologia. Belo Horizonte, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Pesquisa Clinica Evandro Chagas. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Microbiologia Paulo Goés. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Bioquímica Médica Leopoldo de Meis. Rio de Janeiro, RJ, Brasil.University of Pittsburgh. Center for Vaccine Research. Pittsburgh, PA, USA / Fundação Oswaldo Cruz. Centro de Pesquisa Aggeu Magalhães. Laboratório de Virologia e Terapia Experimental. Recife, RJ, Brasil.University of Pittsburgh. Center for Vaccine Research. Pittsburgh, PA, USA / Fondazione RiMED. Palermo, Italy.The probiotic yeast Saccharomyces cerevisiae var boulardii is widely used as a low cost and efficient adjuvant against gastrointestinal tract disorders such as inflammatory bowel disease and treatment of several types of diarrhea, both in humans and animals. S. boulardii exerts its protective mechanisms by binding and neutralizing enteric pathogens or their toxins, by reducing inflammation and by inducing the secretion of sIgA. Although several S. cerevisiae strains have proven probiotic potential in both humans and animals, only S. boulardii is currently licensed for use in humans. Recently, some researchers started using S. boulardii as heterologous protein expression systems. Combined with their probiotic activity, the use of these strains as prophylactic and therapeutic proteins carriers might result in a positive combined effort to fight specific diseases. Here, we provide an overview of the current use of S. cerevisiae strains as probiotics and their mechanisms of action. We also discuss their potential to produce molecules with biotherapeutic application and the advantages and hurdles of this approach. Finally, we suggest future directions and alternatives for which the combined effort of specific immunomodulatory effects of probiotic S. cerevisiae strains and ability to express desired foreign genes would find a practical application.ProbioticsSaccharomyces cerevisiaeSaccharomyces cerevisiae var boulardiiMechanisms of actionExpression of heterologous proteinsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/34762/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALve_Palma_Mariana_etal_INI_2015.pdfve_Palma_Mariana_etal_INI_2015.pdfapplication/pdf368635https://www.arca.fiocruz.br/bitstream/icict/34762/2/ve_Palma_Mariana_etal_INI_2015.pdf80e98a505f4962b36062533902168e0cMD52TEXTve_Palma_Mariana_etal_INI_2015.pdf.txtve_Palma_Mariana_etal_INI_2015.pdf.txtExtracted texttext/plain45144https://www.arca.fiocruz.br/bitstream/icict/34762/3/ve_Palma_Mariana_etal_INI_2015.pdf.txt0f6b2ba037a86f6a583464fe2c327d03MD53icict/347622021-03-24 16:32:35.241oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-03-24T19:32:35Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? |
title |
Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? |
spellingShingle |
Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? Palma, Mariana L. Probiotics Saccharomyces cerevisiae Saccharomyces cerevisiae var boulardii Mechanisms of action Expression of heterologous proteins |
title_short |
Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? |
title_full |
Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? |
title_fullStr |
Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? |
title_full_unstemmed |
Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? |
title_sort |
Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? |
author |
Palma, Mariana L. |
author_facet |
Palma, Mariana L. Zamith-Miranda, Daniel Martins, Flaviano S. Bozza, Fernando A. Nimrichter, Leonardo Montero-Lomeli, Mônica Marques, Ernesto T. A. Douradinha, Bruno |
author_role |
author |
author2 |
Zamith-Miranda, Daniel Martins, Flaviano S. Bozza, Fernando A. Nimrichter, Leonardo Montero-Lomeli, Mônica Marques, Ernesto T. A. Douradinha, Bruno |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Palma, Mariana L. Zamith-Miranda, Daniel Martins, Flaviano S. Bozza, Fernando A. Nimrichter, Leonardo Montero-Lomeli, Mônica Marques, Ernesto T. A. Douradinha, Bruno |
dc.subject.en.pt_BR.fl_str_mv |
Probiotics Saccharomyces cerevisiae Saccharomyces cerevisiae var boulardii Mechanisms of action Expression of heterologous proteins |
topic |
Probiotics Saccharomyces cerevisiae Saccharomyces cerevisiae var boulardii Mechanisms of action Expression of heterologous proteins |
description |
2020-08-13 |
publishDate |
2015 |
dc.date.issued.fl_str_mv |
2015 |
dc.date.accessioned.fl_str_mv |
2019-08-13T12:52:08Z |
dc.date.available.fl_str_mv |
2019-08-13T12:52:08Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
PALMA, Mariana L. et al. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? Applied Microbiology and Biotechnology, v. 99, p. 6563-6570, 2015. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/34762 |
dc.identifier.issn.pt_BR.fl_str_mv |
0175-7598 |
dc.identifier.doi.none.fl_str_mv |
10.1007/s00253-015-6776-x |
dc.identifier.eissn.none.fl_str_mv |
1432-0614 |
identifier_str_mv |
PALMA, Mariana L. et al. Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? Applied Microbiology and Biotechnology, v. 99, p. 6563-6570, 2015. 0175-7598 10.1007/s00253-015-6776-x 1432-0614 |
url |
https://www.arca.fiocruz.br/handle/icict/34762 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Springer |
publisher.none.fl_str_mv |
Springer |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/34762/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/34762/2/ve_Palma_Mariana_etal_INI_2015.pdf https://www.arca.fiocruz.br/bitstream/icict/34762/3/ve_Palma_Mariana_etal_INI_2015.pdf.txt |
bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 80e98a505f4962b36062533902168e0c 0f6b2ba037a86f6a583464fe2c327d03 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813008893384589312 |